Thomas Gottschalk’s Battle with Rare Epithelioid Angiosarcoma: Symptoms, Treatment, and Prognosis
Table of Contents
A beloved figure in German television, Thomas Gottschalk, 75, revealed over the weekend that he is battling epithelioid angiosarcoma, a remarkably rare and aggressive form of cancer. The diagnosis, made public after undergoing surgery four months ago, has prompted questions about the disease, its treatment options, and the challenges patients face. Gottschalk and his wife, Karina, shared the news with the German newspaper Bild, disclosing that parts of his ureters and bladder had to be removed during the procedure.
Understanding Epithelioid Angiosarcoma
According to the US Mayo Clinic, epithelioid angiosarcoma is a rare subtype of angiosarcoma, a cancer originating in the cells lining blood and lymph vessels – known as endothelial cells. While most commonly found in the skin and soft tissues, it can, in extremely rare instances, affect internal organs like the bladder.
The symptoms of this cancer are highly dependent on its location. In Gottschalk’s case, affecting the bladder, a key indicator was blood in the urine. Angiosarcomas generally represent only 1 to 2 percent of all soft tissue sarcomas, with an annual incidence of just a few cases per million people. The epithelioid subtype is even less common, with bladder cases being particularly isolated.
The Cause and Treatment of This Rare Cancer
The exact cause of epithelioid angiosarcoma remains unknown. However, the Mayo Clinic indicates that the cancer arises from changes in the DNA of soft tissue cells, leading to uncontrolled cell growth. The epithelioid form, distinguished by its resemblance to skin cells under a microscope, is especially rare and typically affects older adults – aligning with Gottschalk’s age. Increased risk is also associated with prior radiation therapy or long-term lymphedema (chronic swelling of the lymph system).
Treatment typically involves surgical removal of the diseased tissue. Surgeons aim to remove not only the tumor itself but also a margin of surrounding healthy tissue to ensure complete eradication of cancerous cells. Following surgery, chemotherapy or radiation therapy may be administered to eliminate any remaining cancer cells in the body.
A Challenging Prognosis
Unfortunately, the prognosis for epithelioid angiosarcoma is often unfavorable. Recurrences – the return of the cancer after a period of improvement – and metastases (the spread of cancer to other parts of the body) are common. According to the German Sarcoma Foundation, the two-year survival rate for patients who have already experienced metastasis is a sobering 13 percent.
This diagnosis presents a significant challenge for Gottschalk, and the coming months will be critical as he navigates treatment and recovery. The rarity of this cancer underscores the need for continued research and improved understanding of its complexities.
